Blood and Marrow Transplant
Blood and marrow transplant, or BMT, specialists at The University of Kansas Cancer Center have made almost immediate donor matches possible for those waiting for a transplant. Our recent advances in half-matched donor transplant, referred to as haploidentical, have allowed for a much broader range of donors. Our physicians can identify an appropriate donor for almost every patient, potentially saving more lives.
This means a donor can be found almost immediately for nearly every patient who needs a BMT transplant to be cured.
A need for treatment
Tens of thousands of adults and children in the U.S. are diagnosed each year with leukemia, lymphoma, myeloma and other blood diseases. For many, the only effective treatment option is a blood and marrow transplant.
BMT has become a successful treatment because it enables physicians to treat these diseases with aggressive chemotherapy and/or radiation. BMT allows replacement of the diseased or damaged bone marrow after treatment.
Our BMT program provides patients with innovative and lifesaving transplant therapies.
Types of transplant
Our highly trained specialists perform a variety of blood and marrow transplant procedures. The type of transplant each patient receives is determined by diagnosis, stage of disease, overall health and age. Transplant types include:
Blood and Marrow Transplant: Fast Facts
• More than 3,000 successful transplant procedures to date
• 323 transplants in 2015
• Region's first BMT program accredited by the Foundation for Accreditation of Cellular Therapy (FACT)
• Region's largest BMT and acute leukemia program: The widest range of treatment options
• Only National Marrow Donor Program-approved collection center in Kansas
- Autologus – The patient's own harvested cells are placed back into the body after treatment.
- Allogeneic – Cells from a donor are transplanted to the patient after treatment.
- Matched and mismatched, including haploidentical, related donor
- Matched and mismatched and unrelated donor
- Cord blood
- Myeloablative, nonmyeloablative and reduced intensity
- Syngeneic – Donor and recipient are identical twins
Become a bone marrow donor
Every year, more than 35,000 people throughout the nation are diagnosed with cancer and other life-threatening blood disorders that are treated with a blood and/or marrow transplant. Unfortunately only about 30 percent of patients in need of a BMT find a matched "related donor" in his or her family. The remaining 70 percent rely upon the hopes of finding a matched "unrelated donor" through the National Marrow Donor Program's worldwide database. Learn more.
If the donor is a relative, the transplant is called a related donor transplant. If the donor is unrelated, the transplant is called an unrelated donor transplant.
Stem cells for an allogeneic transplant can be harvested with traditional methods, using bone marrow or peripheral blood stem cells. An additional source of stem cells can be found in the blood inside a newborn's umbilical cord.
Researchers at The University of Kansas Cancer Center are discovering new ways to use a patient’s own immune system to fight non-Hodgkin lymphoma.
Find out if you’re a candidate for this clinical trial.
We perform blood and marrow transplants for various diseases, including:
- Acute myelogenous leukemia
- Acute lymphoblastic leukemia
- Chronic lymphocytic leukemia
- Chronic myelogenous leukemia
- Burkitt's lymphoma
- Hodgkin lymphoma (“Hodgkin’s disease”)
- Mantle Cell lymphoma
- Non-Hodgkin lymphoma
- Multiple myeloma
- Myelodysplastic syndromes
- Myeloproliferative disorders
Other blood disorders and solid tumors we treat include:
- Aplastic anemia
- Ewing’s sarcoma
- Renal cell carcinoma
- Severe combined immune deficiency (SCID)
- Testicular/germ cell tumors
- Waldenstrom's macroglobulinemia
To make an appointment:
Toll Free Call: 844-323-1227
Toll Free Call: 877-588-5862
Why Choose The University of Kansas Cancer Center
Multidisciplinary team providing advanced care with compassion
Make a gift
Fund programs that provide compassion, comfort and the best diagnostic and treatment equipment for cancer patients in the Blood and Marrow Transplant Program. Give now.
At The University of Kansas Cancer Center, a multidisciplinary team provides you with the latest advances in technology and research, delivered with compassionate care.
You benefit from the expertise of specialists in imaging, pathology, medical and radiation oncology, surgery, risk counseling and prevention therapies. Together, we develop a treatment plan tailored to your diagnosis and needs.
- Leading-edge techniques minimize patient admission to the hospital whenever possible. Convenient outpatient services are provided at our Richard and Annette Bloch Cancer Care Pavilion in Westwood, Kansas. This state-of-the art facility is designed to meet the medical and personal needs of patients and their families.
- Our care team closely manages each patient's preparation, treatment and recovery. All BMT patients are treated in a safe and private environment. To protect patients from infection, care areas are isolated from those frequented by the general public.
- Patients receive care from trained BMT nurses and support staff, who help with every aspect of the transplant experience, including nutrition, managing side effects and emotional support.
Second opinion service
If you have been diagnosed with leukemia, lymphoma, myeloma or another blood disease, we can provide you with a second opinion. Asking for a second opinion doesn't mean you think the first diagnosis is wrong or you have doubts about your doctor. Rather, it's a good way for you to get more information about your treatment options.
Learn about the BMT program at The University of Kansas Hospital.